RT Journal Article
SR Electronic
T1 Resting heart rate as a biomarker for tracking change in cardiorespiratory fitness of UK adults: The Fenland Study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.01.20144154
DO 10.1101/2020.07.01.20144154
A1 Gonzales, Tomas I.
A1 Jeon, Justin Y.
A1 Lindsay, Timothy
A1 Westgate, Kate
A1 Perez-Pozuelo, Ignacio
A1 Hollidge, Stefanie
A1 Wijndaele, Katrien
A1 Rennie, Kirsten
A1 Forouhi, Nita
A1 Griffin, Simon
A1 Wareham, Nick
A1 Brage, Soren
YR 2020
UL http://medrxiv.org/content/early/2020/07/02/2020.07.01.20144154.abstract
AB Aims Resting heart rate (RHR) is inversely associated with cardiorespiratory fitness (CRF) but few studies have investigated the nature of this relationship in large population samples. We examined the association between RHR and CRF in UK adults and explored factors that may influence this relationship.Methods and Results In a population-based sample of 5,143 men and 5,722 women (aged 29-65 years), mean (SD) RHR while seated, supine, and during sleep was 67.6 (9.8), 63.5 (8.9), and 56.9 (6.9) bpm, respectively. The age- and sex-adjusted association with CRF as assessed by submaximal treadmill testing was −0.26 (95%CI −0.27; −0.24), −0.31 (95%CI −0.33; −0.29), and −0.31 (95%CI −0.34; −0.29) ml O2 kg-1 beat-1. Sequential adjustment for objectively measured obesity and physical activity attenuated the RHR coefficient by 10% and 50%, respectively. In longitudinal analyses of 6,589 participants re-examined after 6 years, each 1 bpm increase in supine RHR was associated with 0.23 (95%CI 0.20; 0.25) ml O2 min-1 kg-1 decrease in CRF.Conclusions Across all measures, RHR is inversely associated with CRF; half of this association is explained by obesity and physical activity, suggesting CRF changes achieved through altered behaviour could be tracked through changes in RHR, a notion supported by longitudinal results. As well as its utility as a biomarker of CRF at population-level, serial measurements of RHR may facilitate personal goal setting/evaluation and remote patient monitoring.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors were supported by the UK Medical Research Council (MC_UU_12015/1, MC_UU_12015/3, MC_UU_12015/4, MC_UU_12015/5) and the NIHR Cambridge Biomedical Research Centre in Cambridge (IS-BRC-1215-20014).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study complies with the Declaration of Helsinki and was approved by the Health Research Authority NRES Committee East of England-Cambridge Central. All participants gave written informed consent. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data analysed during the current study are not publicly available because we have not obtained consent for public data sharing from the study participants.